Screening for tardive dyskinesia involves asking about movement changes and observing relevant body regions. Clinicians may use a structured tool such as the Abnormal Involuntary Movement Scale to document findings and follow change. A scale…Continue Reading

Treatment decisions for tardive dyskinesia depend on severity, functional impact, current medication needs and available options. Clinicians review the causative exposure and may consider adjustments or switching, while recognising that psychiatric stability must also be…Continue Reading

Risk of tardive dyskinesia is influenced by treatment exposure and individual factors. Longer cumulative exposure to dopamine receptor-blocking medicines is relevant, but the condition does not occur in everyone. Age, previous movement effects and other…Continue Reading